Sutro Biopharma Inc (STRO)
NASDAQ:STRO
Holding STRO?
Track your performance easily

Sutro Biopharma (STRO) Financial Statements

552 Followers

Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently ―. The company's EPS TTM is $-1.842; its P/E ratio is -1.90; Sutro Biopharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 25.71M$ 13.01M$ 113.72M$ 16.92M$ 10.41M
Gross Profit$ 25.71M$ 13.01M$ 113.72M$ 16.92M$ 10.41M
EBIT$ -48.01M$ -48.82M$ 55.60M$ -47.15M$ -37.97M
EBITDA$ -43.56M$ -47.05M$ 57.34M-$ -38.08M
Net Income Common Stockholders$ -48.02M$ -58.21M$ 31.07M$ -40.57M$ -38.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 425.99M$ 313.22M$ 375.62M$ 355.15M$ 391.64M
Total Assets$ 489.04M$ 403.40M$ 470.74M$ 431.73M$ 464.90M
Total Debt$ 26.53M$ 28.07M$ 33.63M$ 38.17M$ 42.66M
Net Debt$ -399.47M$ -285.15M$ -341.98M$ -316.98M$ -348.99M
Total Liabilities$ 336.87M$ 305.38M$ 321.09M$ 319.39M$ 310.18M
Stockholders Equity$ 152.18M$ 98.05M$ 149.65M$ 112.35M$ 154.70M
Cash Flow-
Free Cash Flow$ 9.46M$ -64.74M$ 12.63M-$ -31.20M
Operating Cash Flow$ 9.46M$ -64.74M$ 14.07M$ -33.50M$ -31.20M
Investing Cash Flow$ -80.38M$ 64.11M$ -23.51M$ -114.02M$ 66.16M
Financing Cash Flow$ 96.49M$ -3.43M$ -3.13M$ -5.74M$ 137.66M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Sutro Biopharma Debt to Assets

Sutro Biopharma Cash Flow

Sutro Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis